Y5U-56010-46979

3 vaccinations 13 coded responses 33 check-ins 13 free-text entries 0 call cases

Sex: Female
Age at first dose: 61-65
ZIP prefix: 212 / MD
Registered: 2021-01-22

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-19
Dose 1 — Pfizer-BioNTech
2021-01-22
Registered in v-safe
2021-01-22
Survey response — days 1–6 daily, dose 1
MedDRA: Cough, Decreased appetite — Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Mild coughing, loss of appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-23
Survey response — days 1–6 daily, dose 1
MedDRA: Bronchitis — Feeling: Poor · Chills, Headache, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities

Free text: Bronchitis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-24
Survey response — days 1–6 daily, dose 1
MedDRA: Bronchitis, Decreased appetite — Feeling: Poor · Chills, Headache, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities

Free text: Loss of appetite, bronchitis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-25
Survey response — days 1–6 daily, dose 1
MedDRA: Cough — Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Mild coughing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Survey response — day 7, dose 1
MedDRA: Cough — Feeling: Good · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Slight mild cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-02
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-09
Survey response — day 21, dose 1
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Occasional fatigue especially when walking or climbing stairs.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Dose 2 — Pfizer-BioNTech
2021-02-11
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-02-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness

Adult check-in
2021-02-13
Survey response — days 1–6 daily, dose 2
MedDRA: Malaise, Respiratory tract congestion — Feeling: Fair · Chills, Fatigue or tiredness

Free text: Mild congestion & mild general malaise

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-18
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-11
Survey response — day 28, dose 2
MedDRA: Fatigue, Headache, Sinus pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Recurring headaches, sinus pain, fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-18
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-16
Dose 3 — Pfizer-BioNTech
2021-10-20
Survey response — days 1–6 daily, dose 3
MedDRA: Cough, Nasal congestion, Sinus pain — Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Mild cough, sinus pain, light nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2021-10-21
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-22
Survey response — days 1–6 daily, dose 3
MedDRA: Fatigue — Feeling: Good · Fatigue or tiredness

Free text: Mild fatigue beginning yesterday evening through today

MedDRA releases: 2024-11 · check-in free text available
2021-10-23
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-30
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-08
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-13
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-20
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-11-27
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-01-15
Survey response — 3 months, dose 3
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Occasionally very fatigued

MedDRA releases: 2024-11 · check-in free text available
2022-04-16
Survey response — 6 months, dose 3
MedDRA: Blood pressure increased, Dyspnoea, Pain in extremity — Feeling: Good · Be unable to do your normal daily activities

Free text: Occasional shortness of breath, occasional elevated blood pressure and leg pain

MedDRA releases: 2024-11 · check-in free text available
2022-10-18
Survey response — 12 months, dose 3
MedDRA: Influenza like illness, Tendonitis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Intermittent flu like symptoms that occur monthly and last 3-5 days. Tendonitis

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-19	Pfizer-BioNTech
2	2021-02-11	Pfizer-BioNTech
3	2021-10-16	Pfizer-BioNTech	No

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-22

Systemic reaction (other): Mild coughing, loss of appetite

2021-01-23

Systemic reaction (other): Bronchitis

2021-01-24

Systemic reaction (other): Loss of appetite, bronchitis

2021-01-25

Systemic reaction (other): Mild coughing

Release 2 — day 7, dose 1

2021-01-26

Systemic reaction (other): Slight mild cough

Release 3 — day 21, dose 1

2021-02-09

Symptoms: Occasional fatigue especially when walking or climbing stairs.

Release 4 — days 1–6 daily, dose 2

2021-02-13

Systemic reaction (other): Mild congestion & mild general malaise

Release 5 — day 28, dose 2

2021-03-11

Symptoms: Recurring headaches, sinus pain, fatigue

Release 10 — days 1–6 daily, dose 3

2021-10-20

Systemic reaction (other): Mild cough, sinus pain, light nasal congestion

2021-10-22

Systemic reaction (other): Mild fatigue beginning yesterday evening through today

Release 10 — 3 months, dose 3

2022-01-15

Symptoms: Occasionally very fatigued

Release 11 — 6 months, dose 3

2022-04-16

Symptoms: Occasional shortness of breath, occasional elevated blood pressure and leg pain

Release 12 — 12 months, dose 3

2022-10-18

Symptoms: Intermittent flu like symptoms that occur monthly and last 3-5 days. Tendonitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Blood pressure increased	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Influenza like illness	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Sinus pain	✓	✓	✓
SD	Tendonitis	·	·	✓
SRO	Bronchitis	✓	✓	✓
SRO	Cough	✓	✓	✓
SRO	Decreased appetite	✓	✓	✓
SRO	Fatigue	·	·	✓
SRO	Malaise	✓	✓	✓
SRO	Nasal congestion	·	·	✓
SRO	Respiratory tract congestion	✓	✓	✓
SRO	Sinus pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release